SHARE

Sigma Labs Inc (OTCMKTS:SGLB) noted in a press release that it has earned to become a Silver member of the America Makes. As known, America Makes is a National Additive Manufacturing Innovation Institute (NAMII) and thus, the inclusion of the company as its member is an important milestone.

Became member of America Makes

While giving more details about the development, Sigma Labs Inc (OTCMKTS:SGLB)’s President and CEO, Mark Cola said that the company achieved the membership status of NAMMI after contributing it a number of work years. He said that the achievement makes more sense as the company endeavors to scale up its presence in the field of 3D printing.

Also, becoming a member of America Makes holds importance as it will help the company associate with a number of front running companies and organizations. Since the company already bagged awards for spreading the awareness about its patented PrintRite3D software, it’s joining the NAMII will further enhance and display its unique capabilities. The PrintRite3D has been developed with the goal of eliminating the quality inspection post-production by including it within the production cycle.

Anticipating more aerospace contracts

Sigma Labs Inc (OTCMKTS:SGLB) recently received a research project award from America Makes with respect to In-Process Quality Assurance. The main aim of the research project was to attain high-volume production of aerospace parts. On successful execution of which, the company gained its first contract from GE Aviation in early 2015.

Moreover, the company is anticipating more contracts from Aerojet Rocket dyne and Honeywell Aerospace. Although Sigma Labs Inc (OTCMKTS:SGLB) fell behind the timeline in commercializing its PrintRite3D software, there are hopes that the company will pick up faster now.

The stock of Sigma Labs Inc (OTCMKTS:SGLB) sat constant at $0.112 on the bourses during the last session while the ticker recorded an average volume of 1.61 million.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

https://www.journaltranscript.com/disclaimer

LEAVE A REPLY